SCHEMBL25859233

SCHEMBL25859233

C=C1COc2ccccc2C1[C@@](O)(N[S@+]([O-])C(C)(C)C)C(=O)OCC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.35
PPARG P37231 1/20 0.33
MMP8 P22894 1/20 0.31
MAPT P10636 2/20 0.31
GAA P10253 2/20 0.31
SSTR4 P31391 1/20 0.31
MGAM O43451 1/20 0.31
AMY1A P0DUB6 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
PKM P14618 1/20 0.30
NR3C1 P04150 1/20 0.30
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
GLA P06280 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30
ATM Q13315 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25859593 0.81
SCHEMBL25859235 0.78 POLB (0.38) POLBPPARGMAPTGAAMGAM
SCHEMBL25854610 0.77 POLB (0.36) POLBMAPTGAASSTR4MGAM
SCHEMBL25526051 0.68 HTR2A (0.32) SSTR4
SCHEMBL25859093 0.66 ACE (0.33) POLBMMP8ALDH1A1ATM
SCHEMBL25854541 0.66 ACE (0.33) POLBMMP8ALDH1A1ATM
SCHEMBL25854605 0.66 GAA (0.39) POLBMAPTGAAMGAMAMY1A
SCHEMBL25854609 0.65 GAA (0.41) POLBMAPTGAAMGAMAMY1A
SCHEMBL25854661 0.64 PKM (0.30) PKM
SCHEMBL5798239 0.62 POLB (0.41) POLBMMP8MAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227437-A1 IMMUNOMODULATOR HITGEN INC (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227437-A1 IMMUNOMODULATOR IL17A, IL2, IL2RA POLB 3397/4885PPARG 432/4885MMP8 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.